City of Hope

www.cityofhope.org

 

City of Hope
M

2019 ESMO Update: Phase 1 Study of AMG 510, a Novel KRAS G12C Inhibitor in Advanced Solid Tumors w/KRAS G12C Mutation

By City of Hope FEATURING Marwan G. Fakih
By City of Hope FEATURING Marwan G. Fakih
424 views
November 29, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley
General Oncology
13:16

Universal Comprehensive Genomic Profiling and Treatment Planning

Total Health

R. Salgia

327 views
17:50

Breast/Ovarian Cancer Genetic Risk Assessment: BRCA1/2, PALB2 & CHEK…

UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

J. Weitzel

27 views
12:31

2019 ESMO Update: Phase 1 Study of AMG 510, a Novel KRAS G12C Inhibi…

City of Hope

M. Fakih

424 views